medigraphic.com
ISSN 2305-7939 (Electronic)

2014, Number 2

<< Back

RCU 2014; 3 (2)

Resultados preliminares del programa integral de diagnóstico estandarizado por etapas, para el tratamiento de la Hiperplasia prostática benigna

Apolikhin OI, Sivkov AV, Katibov MI, Zolotukhin OV, Shaderkin IA, Prosyannikov MYU, Grigorieva MV, Voitko DA, Tsoi AA

Language: Spanish
References: 14
Page: 52-55
PDF size: 681.09 Kb.


ABSTRACT

No abstract.


REFERENCES

  1. Shepin O.P., Tishuk E.I. Problems of demographic development of Russia. // The health economy. 2005. Vol 3. С. 5-8.

  2. Temml C, Brössner C, Schatzl G, Ponholzer A, Knoepp L, Madersbacher S, et al. The natural history of lower urinary tract symptoms over five years. Eur Urol. 2003;43(4):374-80.

  3. Kok ET, Schouten BW, Bohnen AM, Groeneveld FP, Thomas S, Bosch JR. Risk factors for lower urinary tract symptoms suggestive of benign prostatic hyperplasia in a community based population of healthy aging men: the Krimpen Study. J Urol. 2009;181(2):710-6.

  4. Schulman CC. The aging male: a challenge for urologists. Curr Opin Urol. 2000;10(4):337-45.

  5. Kaplan SA, Olsson CA, Te AE. The American Urological Association symptom score in the evaluation of men with lower urinary tract symptoms: at 2 years of followup, does it work? J Urol. 1996;155(6):1971-4.

  6. Rosen R, Altwein J, Boyle P, Kirby RS, Lukacs B, Meuleman E, et al. Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7). Eur Urol. 2003;44(6):637-49.

  7. Farmer R, Clifford JG. Incidence and prevalence of LUTS/BPH in the UK in the 1990. BJU Int. 2002;90(Suppl 2):74.

  8. Loh S-Y, Chin C-M. A demographic profile of patients undergoing transurethral resection of the prostate for benign prostate hyperplasia and presenting in acute urinary retention. BJU Int. 2002;89(6):531-3.

  9. Bruskewitz R. Management of symptomatic BPH in the US: who is treated and how? Eur Urol. 1998;36:7-13.

  10. Garraway WM, Lee RJ, Collins GN. High prevalence of benign prostatic hypertrophy in the community. The Lancet. 1991;338(8765):469-71.

  11. Kohnen PW, Drach GW. Patterns of inflammation in prostatic hyperplasia: a histologic and bacteriologic study. J Urol. 1979;121(6):755-60.

  12. Roth S., Buzeline J.M., Delauche-Cavallier M.C. et al. Correlation between symptomatic improve-ment assessed by Boyarsky and I-PSS symptom scores in patients with benign prostatic hy-perplasia (BPH). Eur. Urol. 1996. - Vol. 30, Supp. 2. : 57

  13. Apalachin I., A.V. Sivkov, Katibu M.I., A.V. Shchukin, Zolotukhin O.V., Sadikin I.A. et. al. Programm "Urology" - a comprehensive approach to the modernization of health care on the example of Voronezh oblast. Experimental and clinical urology 2013 Vol. 2 : 5

  14. Diener E, Suh E, Oishi S. Recent findings on subjective well-being. Indian J Clin Psychol [Internet]. 1997 [citado 3 de abril de 2015]; Recuperado a partir de: http://psycnet.apa.org/psycinfo/1997-43193-002




2020     |     www.medigraphic.com